MUCOSIL-20 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Mucosil-20, and when can generic versions of Mucosil-20 launch?
Mucosil-20 is a drug marketed by DEY and is included in one NDA.
The generic ingredient in MUCOSIL-20 is acetylcysteine. There are three drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the acetylcysteine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Mucosil-20
A generic version of MUCOSIL-20 was approved as acetylcysteine by HOSPIRA on August 30th, 1994.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MUCOSIL-20?
- What are the global sales for MUCOSIL-20?
- What is Average Wholesale Price for MUCOSIL-20?
Summary for MUCOSIL-20
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 158 |
| Patent Applications: | 3,577 |
| DailyMed Link: | MUCOSIL-20 at DailyMed |
US Patents and Regulatory Information for MUCOSIL-20
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dey | MUCOSIL-20 | acetylcysteine | SOLUTION;INHALATION, ORAL | 070576-001 | Oct 14, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
